Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme

Ring, Christopher J. ORCID: https://orcid.org/0000-0002-9278-0942, Blouin, P., Martin, L. A., Hurst, H. C. and Lemoine, N. R. (1997) Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme. Gene therapy, 4 (10) . pp. 1045-1052. ISSN 0969-7128 [Article]

Abstract

In order to exploit differences in gene expression between normal and malignant cells for genetic prodrug-activation therapy, we have generated recombinant retroviruses containing the herpes simplex virus thymidine kinase coding region cloned downstream of sequences derived from the 5'-flanking regions of the MUC1 and ERBB2 genes. Transduction with retroviruses containing MUC1 promoters resulted in an increase in GCV sensitivity in MUC1 positive cells. A further increase in GCV sensitivity was achieved when MUC1-positive cells were transduced with retroviruses containing chimeric-MUC1/ERBB2 promoters. No significant sensitization to GCV was observed when MUC1-negative cells were transduced with these recombinant retroviruses. These results suggest that one may be able to develop a tumour-selective therapy by utilizing the transcriptional regulatory regions of the MUC1 and ERBB2 genes to drive the expression of suicide genes.

Item Type: Article
Research Areas: A. > School of Science and Technology > Natural Sciences
ISI Impact: 43
Item ID: 3313
Useful Links:
Depositing User: Chris Ring
Date Deposited: 03 Dec 2009 09:07
Last Modified: 13 Oct 2016 14:16
URI: https://eprints.mdx.ac.uk/id/eprint/3313

Actions (login required)

View Item View Item